Korean J Otolaryngol-Head Neck Surg.  2002 Oct;45(10):1004-1009.

Neoadjuvant Chemotherapy and Radiotherapy for the Treatment of Squamous Cell Carcinoma of the Tonsil

Affiliations
  • 1Department of Otolaryngology, College of Medicine, Busan National University, Busan, Korea. wangsg@pusan.ac.kr
  • 2Department of Radiation Oncology, College of Medicine, Busan National University, Busan, Korea.

Abstract

BACKGROUND AND OBJECTIVES: Squamous cell carcinoma of the tonsil has a relatively poor prognosis. Surgery, radiation therapy and combinations of irradiation and surgery have been employed but there exists some controversy about the efficacy of these treatment modalities. The purpose of this study was to evaluate the efficacy of the neoadjuvant chemotherapy and radiotherapy in the treatment of tonsillar neoplasm. MATERIALS AND METHOD: Medical records of 21 patients who received neoadjuvant chemotherapy and radiotherapy for tonsillar neoplasm at Pusan National University Hospital from April 1995 through August 2000 were retrospectively reviewed.
RESULTS
The three year survival rate was 81.0%. The three year survival rates for stages I,II were both 100%. For stages III, IV, the rates were 83.3%, 87.5%, respectively. The three year survival rate for T1, T2, T3 were 100%, 92.3%, 40.0%, respectively.
CONCLUSION
Neoadjuvant chemotherapy and radiotherapy would be effective treatment modality for tonsillar neoplasm with high survival rate and low morbidity.

Keyword

Tonsillar neoplasms; Radiotherapy; Neoadjuvant chemotherapy

MeSH Terms

Busan
Carcinoma, Squamous Cell*
Drug Therapy*
Humans
Medical Records
Palatine Tonsil*
Prognosis
Radiotherapy*
Retrospective Studies
Survival Rate
Tonsillar Neoplasms
Full Text Links
  • KJORL-HN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr